MyFinsight
Home
Blog
About
Contact
Investments
$10,918,778
Cash and cash
equivalents
$3,124,523
Prepaid expenses and
other current assets
$1,291,256
Total current assets
$15,334,557
Intangible assets, net
$358,334
Total assets
$15,692,891
Total liabilities and
shareholders' equity
$15,692,891
Total shareholders'
equity
$8,773,132
Total liabilities
$6,919,759
Accumulated deficit
-$75,968,182
Accumulated other
comprehensive loss
-$159
Additional paid in capital
$84,741,473
Total current
liabilities
$5,346,026
Due to officers -
long term
$1,573,733
Accrued expenses
$1,823,544
Accounts payable
$1,776,231
Accrued interest and
financing expense
$1,146,251
Due to officers -
short term
$600,000
Back
Back
Balance Sheet
Quoin Pharmaceuticals, Ltd. (QNRX)
Quoin Pharmaceuticals, Ltd. (QNRX)
source: myfinsight.com